To fully characterize these two new high-grade serous ovarian cancer mouse models, we analyzed the RNAseq profiles of MOSE and MKPOSE2-C2 cells before and after Trp53 deletion, and before and after in vivo passaging. The gene discussed is TP53; the disease is ovarian serous adenocarcinoma.